Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)-Reference-Cited by-同舟云学术

Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)

Published:2015 Issue:3 Volume:24 Page:77-105
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

,Ishii Tomohiro¹,Anzo Makoto²,Adachi Masanori³,Onigata Kazumichi⁴,Kusuda Satoshi⁵,Nagasaki Keisuke⁶,Harada Shohei⁷,Horikawa Reiko⁸,Minagawa Masanori⁹,Minamitani Kanshi¹,Mizuno Haruo¹⁰,Yamakami Yuji¹¹,Fukushi Masaru¹²,Tajima Toshihiro¹³

Affiliation:

1. Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan

2. Department of Pediatrics, Kawasaki City Hospital, Kanagawa, Japan

3. Department of Endocrinology and Metabolism, Kanagawa Children’s Medical Center, Kanagawa, Japan

4. Shimane University Hospital Postgraduate Clinical Training Center, Shimane, Japan

5. Maternal and Perinatal Center, Tokyo Women’s Medical University, Tokyo, Japan

6. Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

7. Division of Neonatal Screening, National Center for Child Health and Development, Tokyo, Japan

8. Department of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan

9. Division of Endocrinology, Chiba Children’s Hospital, Chiba, Japan

10. Departments of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

11. Kanagawa Health Service Association, Kanagawa, Japan

12. Sapporo IDL, Sapporo, Japan

13. Department of Pediatrics, Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/24/3/24_2015-0001/_pdf

Reference149 articles.

1. 1. Suwa, S. Nationwide survey of neonatal mass-screening for congenital adrenal hyperplasia in Japan. Screening 1994;3: 141–51.

2. 2. Pang, SY, Wallace, MA, Hofman, L, Thuline, HC, Dorche, C, Lyon, IC, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81: 866–74.

3. 3. Suwa, S. Congenital adrenal hyperplasia. Jpn J Pediatr Med 1994;26: 1967–72 (in Japanese).

4. 4. Fujieda, K. History and current status of neonatal mass screening for congenital adrenal hyperplasia. Jpn J Pediatr Med 2001;33: 1674–8 (in Japanese).

5. 5. Suwa, S, Igarashi, Y, Kitagawa, T, Shimozawa, K, Tsuruhara, T, Matsuura, N, et al. Diagnostic handbook of congetal adrenal hyperplasia (21-hydroxylase deficiency) identified by neonatal mass screening. J Jpn Pediatr Soc 1989;93: 1632–3 (in Japanese).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical monitoring of 21-hydroxylase deficiency: a clinical utility of overnight fasting urine pregnanetriol;Current Opinion in Pediatrics;2024-05-31

2. Isotretinoin-unresponsive acne as a sign of a congenital disorder: a case of 21-hydroxylase deficiency;Dermatology Reports;2023-08-24

3. Monitoring treatment in pediatric patients with 21-hydroxylase deficiency;Frontiers in Endocrinology;2023-02-03

4. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision);CLIN PEDIATR ENDOCRI;2022

5. A male neonate failing to thrive with an endocrine disorder;African Journal of Endocrinology and Metabolism;2022-07